Determination of the effects of eNOS gene polymorphisms (T-786C and Glu298Asp) on nitric oxide levels in a methylmercury-exposed population

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 74, Issue 20, 2011, Pages 1323-1333

  De Marco, Kátia Cristina ^a   Braga, Gilberto U ^a   Barbosa Jr , Fernando ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; METHYLMERCURY; NITRIC OXIDE; NITRITE;

ADULT; ADVERSE OUTCOME; AGE; AGED; ARTERIAL PRESSURE; ARTICLE; BLOOD SAMPLING; BODY MASS; BRAZIL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; FISH; FOOD CONTAMINATION; GENOTYPE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION EXPOSURE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ASPARTIC ACID; CARDIOVASCULAR DISEASES; FEMALE; GLUTAMIC ACID; HUMANS; MALE; MERCURY; METHYLMERCURY COMPOUNDS; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEAFOOD;

EID: 80052669075     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2011.600665     Document Type: Article

References (58)

1. Barbosa, F., Jr., Sertorio, J. T. C., Gerlach, R. F., and Tanus-Santos, J. E. 2006a. Clinical evidence for lead-induced inhibition of nitric oxide formation. Arch. Toxicol. 80:811-16. (Pubitemid 44833077)
2. Barbosa Jr, F., Sandrim, V. C., Uzuelli, J. A., Gerlach, R. F., and Tanus-Santos, J. E. 2006b. eNOS genotype-dependent correlation between whole blood lead and plasma nitric oxide products concentrations. Nitric Oxide 14:58-64. (Pubitemid 43063509)
3. Baylis, C., and Vallance, P. 1998. Measurement of nitrite and nitrate levels in plasma and urine-What does this measure tell us about the activity of the endogenous nitric oxide system? Curr. Opin. Nephrol. Hypertens. 7:59-62. (Pubitemid 28037522)
4. Berdeli, A., Sekuri, C., Sirri Cam, F., Ercan, E., Sagcan, A., Tengiz, I., Eser, E., and Akin, M. 2005. Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery diseases in a Turkish population. Clin. Chim. Acta 351:87-94. (Pubitemid 39563560)
5. Bernard, A. 2008. Biomarkers of metal toxicity in population studies: Research potential and interpretation issues. J. Toxicol. Environ. Health A 71:1259-65.
6. Bridges, C. C., and Zalups, K. R. 2010. Transport of inorganic mercury and methylmercury in target tissues and organs. J. Toxicol. Environ. Health B 13:385-410.
7. Burger, J., Jeitner, C., and Gochfeld, M. 2011. Locational differences in mercury and selenium levels in 19 species of saltwater fish from New Jersey. J. Toxicol. Environ. Health A 74:863-74.
8. Casas, J. P., Cavalleri, G. L., Bautista, L. E., Smeeth, L., Humphries, S. E., and Hingorani, A. D. 2006. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: A HuGE review. Am. J. Epidemiol. 164:921-35. (Pubitemid 44729832)
9. Cattaruzza, M., Guzik, T. J., Stodowski, W., Pelvan, A., Becker, J., Halle, M., Buchwald, A. B., Channon, K. M., and Hecker, M. 2004. Shear stress insensitivity of endothelial nitric oxide synthase expression as a genetic risk factor for coronary heart disease. Circ. Res. 95:841-47. (Pubitemid 39390587)
10. Çengel, A., and Sahinarslan, A. 2006. Nitric oxide and cardiovascular system. Anadolu Kardiyol. Derg. 6:364-68. (Pubitemid 46128394)
11. Chatterjee, A., and Catravas, J. D. 2008. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vasc. Pharmacol. 49:134-40.
12. Choi, A. L., Weihe, P., Budtz-Jørgensen, E., Jørgensen, P. J., Salonen, J. T., Tuomainen, T. P., Murata, K., Nielsen, H. P., Petersen, M. S., Askham, J., and Grandjean, P. 2009. Methylmercury exposure and adverse cardiovascular effects in Faroese whaling men. Environ. Health Perspect. 17:367-72.
13. Colomba, D., Duro, G., Corrao, S., Argano, C., Di Chiara, T., Nuzzo, D., Pizzo, F., Parrinello, G., Scaglione, R., and Licata, G. 2008. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study. Immun. Ageing 5:4-10.
14. Colombo, M. G., Andreassi, M. G., Paradossi, U., Botto, N., Manfredi, S., Masetti, S., Rossi, G., Clerico, A., and Biagini, A. 2002. Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298→Asp polymorphism) to the presence, extent and severity of coronary artery disease. Heart 87:525-28. (Pubitemid 34547974)
15. Cooke, G. E., Doshi, A., and Binkley, P. F. 2007. Endothelial nitric oxide synthase gene: prospects for treatment of heart disease. Pharmacogenomics 8:1723-34.
16. Ghilardi, G., Biondi, M. L., DeMonti, M., Bernini, M., Turri, O., Massaro, F., Guagnellini, E., and Scorza, R. 2002. Independent risk factor for moderate to severe internal carotid artery stenosis: T786C mutation of the endothelial nitric oxide synthase gene. Clin. Chem. 48:989-93. (Pubitemid 34680892)
17. Grotto, D., Castro, M. M., Barcelos, G. R. M., Garcia, S. C., and Barbosa, F., Jr. 2009. Low level and sub-chronic exposure to methylmercury induces hypertension in rats: nitric oxide depletion and oxidative damage as possible mechanisms. Arch. Toxicol. 83:653-62.
18. Guallar, E., Sanz-Gallardo, M. I., Van't Veer, P., Bode, P., Aro, A., Gómez-Aracena, J., Kark, J. D., Riemersma, R. A., Martín-Moreno, J. M., and Kok, F. J. 2002. Mercury, fish oils, and the risk of myocardial infarction. N. Engl. J Med. 347:1747-54. (Pubitemid 35375613)
19. Guldiken, B., Sipahi, T., Guldiken, S., Ustundag, S., Budak, M., Turgut, N., and Ozkan, H. 2009. Glu298Asp polymorphism of the endothelial nitric oxide synthase gene in Turkish patients with ischemic stroke. Mol. Biol. Rep. 36:1539-43.
20. Hibbs, J. B., Jr., Westenfelder, C., Taintor, R., Vavrin, Z., Kablitz, C., Baranowski, R. L., Ward, J. H., Menlove, R. L., McMurry, M. P., and Kushner, J. P. 1992. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89:867-77.
21. Hingorani, A. D. 2001. Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis 154:521-27. (Pubitemid 32232148)
22. Kishimoto, T., Oguri, T., and Tada, M. 1995. Effect of methylmercury (CH3HgCl) injury on nitric oxide synthase (NOS) activity in cultured human umbilical vascular endothelial cells. Toxicology 103:1-7. (Pubitemid 3007079)
23. Kleinbongard, P., Dejam, A., Lauer, T., Jax, T., Kerber, S., Gharini, P., Balzer, J., Zotz, R. B., Scharf, R. E., Willers, R., Schechter, A. N., Feelisch, M., and Kelm, M. 2006. Plasma nitrite concentrations reflect the degree of endotelial dysfunction in humans. Free Radical Biol. Med. 40 295-302. (Pubitemid 43069353)
24. Kleinbongard, P., Dejam, A., Lauer, T., Rassaf, T., Schindler, A., Picker, O., Sheeren, T., Gödecke, A., Schrader, J., Schulz, R., Heusch, G., Schaub, G. A., Bryan, N. S., Feelisch, M., and Kelm, M. 2003. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radical Biol. Med. 35:790-96. (Pubitemid 37329482)
25. Kleinbongard, P., Keymel, S., and Kelm, M. 2007. New functional aspects of the L-arginine-nitric oxide metabolism within the circulating blood. Thromb. Haemost. 98:970-74. (Pubitemid 350091124)
26. Kuo, T. C., Huang, C. I., and Lin-Shiau, S. Y. 2002. Methylmercury inhibits nitric oxide production mediated by Ca (2+) overload and protein kinase A activation. Toxicology 176:113-22.
27. Leeson, C. P. M., Hingorani, A. D., Mullen, M. J., Jeerooburkhan, N., Kattenhorn, M., Cole, T. J., Muller, D. P. R., Lucas, A., Humphries, S. E., and Deanfield, J. E. 2002. Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Clin. Res. 90:1153-58. (Pubitemid 34786899)
28. Marco, K. C., Passos, C. J. S., Sertorio, J. T., Tanus-Santos, J. E., and Barbosa, F., Jr. 2009. Environmental exposure to methylmercury is associated with a decrease in nitric oxide production. Basic Clin. Pharmacol. Toxicol. 106:411-15.
29. McDonald, D. M., Alp, N. J., and Channon, K. M. 2004. Functional comparison of the endothelial nitric oxide synthase Glu298Asp polymorphic variants in human endothelial cells. Pharmacogenetics 14:831-39. (Pubitemid 40054338)
30. Metzger, I. F., Souza-Costa, D. C., Marroni, A. S., Nagassaki, S., Destac, Z., Flockhart, D. A., and Tanus-Santos, J. E. 2005. Endothelial nitric oxide synthase gene haplotypes associated with circulating concentrations of nitric oxide products in healthy men. Pharmacogenomics 15:565-70. (Pubitemid 41044242)
31. Metzger, I. F., Sertorio, J. T., and Tanus-Santos, J. E. 2007. Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radical Biol. Med. 43:987-92. (Pubitemid 47223635)
32. Mozaffarian, D. 2009. Fish, mercury, selenium and cardiovascular risk: Current evidence and unanswered questions. Int. J. Environ. Res. Public Health 6:1894-916.
33. Nakayama, M., Yasue, H., Yoshimura, M., Shimasaki, Y., Kugiyama, K., Ogawa, H., Motoyama, T., Saito, Y., Ogawa, Y., Miyamoto, Y., and Nakao, K. 1999. T-786-C mutation in the 5-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864-70. (Pubitemid 29258973)
34. Nakayama, M., Yasue, H., Yoshimura, M., Shimasaki, Y., Ogawa, H., Kugiyama, K.
35. Mizuno, Y., Harada, E., Nakamura, S., Ito, T., Saito, Y., Miyamoto, Y., Ogawa, Y., and Nakao, K. 2000. T (-786) C mutation in the 5-Flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am. J. Cardiol. 86:628-34.
36. NIST, 2011. https://www-s.nist.gov/srmors/view-cert.cfm?srm=966. (Accessed July 27, 2011).
37. Palmer, C. D., Lewis, M. E., Jr., Geraghtya, C. M., Barbosa, F., Jr., and Parsons, P. J. 2006. Determination of lead, cadmium and mercury in blood for assessment of environmental exposure: A comparison between inductively coupled plasma-mass spectrometry and atomic absorption spectrometry. Spectrochim. Acta B 61:980-90. (Pubitemid 44636085)
38. Persu, A., Stoenoiu, M. S., Messiaen, T., Davila, S., Robino, C., El-Khattabi, O., Mourad, M., Horie, S., Feron, O., Balligand, J. L., Wattiez, R., Pirson, Y., Chauveau, D., Lens, X. M., and Devuyst, O. 2002. Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum. Mol. Genet. 11:229-41. (Pubitemid 34173352)
39. Rosselli, M., Imthurn, B., Keller, P. J., Jackson, E. K., and Dubey, R. K. 1995. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol and norethisterone acetate. A two-year follow-up study. Hypertension 25:848-53.
40. Rubio, A. R., and Morales-Segura, M. A. 2004. Nitric oxide, an iceberg in cardiovascular physiology: Far beyond vessel tone control. Arch. Med. Res. 35:1-11. (Pubitemid 38249304)
41. Salonen, J. T., Seppänen, K., Nyyssönen, K., Korpela, H., Kauhanen, J., Kantola, M., Tuomilehto, J., Esterbauer, H., Tatzber, F., and Salonen, R. 1995. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation 91:645-55.
42. Salonen, J. T., Seppänen, K., Lakka, T. A., Salonen, R., and Kaplan, G. A. 2000. Mercury accumulation and accelerated progression of carotid atherosclerosis: A population based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis 148:265-73. (Pubitemid 30064457)
43. Savvidou, M. D., Vallance, P. J., Nicolaides, K. H., and Hingorani, A. D. 2001. Endothelial nitric oxide synthase gene polymorphism and maternal vascularadaptation to pregnancy. Hypertension 38:1289-93. (Pubitemid 34033404)
44. Srivastava, K., Narang, R., Sreenivas, V., Das, S., and Das, N. 2008. Association of eNOS Glu298Asp gene polymorphism with essential hypertension in Asian Indians. Clin. Chim. Acta 387:80-83. (Pubitemid 350050936)
45. Stern, A. H. 2005. A review of the studies of the cardiovascular health effects of methylmercury with consideration of their suitability for risk assessment. Environ. Res. 98:133-42. (Pubitemid 40254953)
46. Tamemoto, H., Ishikawa, S., and Kawakami, M. 2008. Association of the Glu298Asp polymorphism of the eNOS Gene with ischemic heart disease in Japanese diabetic subjects. Diabetes Res. Clin. Pract. 80:275-79.
47. Tanus-Santos, J. E., Desai, M., and Flockhart, D. A. 2001 Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 11:719-25. (Pubitemid 33078242)
48. Tesauro, M., Thompson, W. C., Rogliani, P., Qi, L., Chaudhary, P. P., and Moss, J. 2000. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: Cleavage of proteins with aspartate vs. glutamate at position 298. Proc. Natl. Acad. Sci. USA 97:2832-35. (Pubitemid 30159257)
49. Tsuchiya, A., Hinners, T. A., Burbacher, T. M., Faustman, E. M., and Mariën, K. 2008. Mercury exposure from fish consumption within the Japanese and Korean communities. J. Toxicol. Environ. Health A 71:1019-31. (Pubitemid 352000683)
50. Virtanen, J. K., Voutilainen, S., Rissanen, T. H., Mursu, J., Tuomainen, T. P., Korhonen, M. J., Valkonen, V. P., Seppänen, K., Laukkanen, J. A., and Salonen, J. T. 2005. Mercury, fish oils, and risk of acute coronary events and cardiovascular disease, coronary heart disease, and all-cause mortality in men in eastern Finland. Arteriosclerosis Thrombosis Vasc. Biol. 25:228-33. (Pubitemid 40054281)
51. Virtanen, J. K., Rissanen, T. H., Voutilainen, S., and Tuomainen, T. P. 2007. Mercury as a risk factor for cardiovascular diseases. J. Nutr. Biochem. 18:75-85. (Pubitemid 46048990)
52. Walkuska, G., Chalabis-Mazurek, A., and Szkoda, J. 2010. Mercury content in the trophic chain of the Tanew River, Poland, ecosystem. J. Toxicol. Environ. Health A 73:1180-85.
53. Wang, X. L., Mahaney, M. C., Sim, A. S., Wang, J., Wang, J., Blangero, J., Almasy, L., Badenhop, R. B., and Wilcken, D. E. 1997. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arteriosclerosis Thrombosis Vasc. Biol. 17:3147-53. (Pubitemid 28016070)
54. Wang, X. L., and Wang, J. 2000. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol. Genet. Metab. 70:241-51.
55. Yemi̧sçi, M., Sinici, I., Ozkara, H. A., Hayran, M., Ay, H., Celtikçi, B., Onder, E.
56. Büyükşerbetci, G., Kaya, E. B., Tokgözoglu, L., and Dalkara, T. 2009. Protective role of 27bp repeat polymorphism in intron 4 of eNOS gene in lacunar infarction. Free Radical Res. 43:272-79.
57. Yoshimura, M., Yasue, H., Nakayama, M., Shimasaki, Y., Ogawa, H., Kugiyama, K., Saito, Y., Miyamoto, Y., Ogawa, Y., Kaneshige, T., Hiramatsu, H., Yoshioka, T., Kamitani, S., Teraoka, H., and Nakao, K. 2000. Genetic risk factors for coronary artery spasm: Significance of endothelial nitric oxide synthase gene T-786->C and missense Glu298Asp variants. J. Invest. Med. 48:367-74.
58. Zhang, C., Lopez-Ridaura, R., Hunter, D. J., Rifai, N., and Hu, F. B. 2006. Common variants of the endothelial nitric oxide synthase gene and the risk of coronary heart disease among U. S. diabetic men. Diabetes 55:2140-47. (Pubitemid 44509990)